Bristol-Myers Squibb to Take Part at the Wolfe Research Healthcare Conference
Get Alerts BMY Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 4.1%
Revenue Growth %: -4.6%
Join SI Premium – FREE
NEW YORK--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) will take part in a fireside chat at the Wolfe Research Healthcare Conference on Wednesday, November 6, 2019, in New York. Giovanni Caforio, M.D., chairman and chief executive officer will answer questions at 3:10 p.m. ET.
Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. Materials related to the presentation will be available at the same website at the start of the live webcast. An archived edition of the session will be available later that day.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191030006014/en/
Media: Carrie Fernandez, 609-252-5222, [email protected]
Investors: Tim Power, 609-252-7509, [email protected]
Source: Bristol-Myers Squibb Company
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Qnity to Present at the Wolfe Research Materials of the Future Conference
- Grey Wind Capital Partners with Maher Services and F. G. Sullivan to Build a Leading New England Water Well Services Platform
- Make Music Ventura: A FREE day of live music, community celebration, and hands-on fun for all ages
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share